Positive News SentimentPositive NewsNASDAQ:SERA Sera Prognostics (SERA) Stock Forecast, Price & News $1.91 +0.13 (+7.30%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$1.73▼$1.9550-Day Range$1.55▼$3.2452-Week Range$1.10▼$4.25Volume88,753 shsAverage Volume487,499 shsMarket Capitalization$59.74 millionP/E RatioN/ADividend YieldN/APrice Target$2.75 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Sera Prognostics MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside44.0% Upside$2.75 Price TargetShort InterestHealthy0.84% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.75Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($1.28) to ($1.30) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.29 out of 5 starsMedical Sector365th out of 964 stocksMedical Laboratories Industry10th out of 23 stocks 3.3 Analyst's Opinion Consensus RatingSera Prognostics has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.75, Sera Prognostics has a forecasted upside of 44.0% from its current price of $1.91.Amount of Analyst CoverageSera Prognostics has only been the subject of 2 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.84% of the float of Sera Prognostics has been sold short.Short Interest Ratio / Days to CoverSera Prognostics has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sera Prognostics has recently decreased by 14.05%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSera Prognostics does not currently pay a dividend.Dividend GrowthSera Prognostics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SERA. Previous Next 3.8 News and Social Media Coverage News SentimentSera Prognostics has a news sentiment score of 1.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Sera Prognostics this week, compared to 1 article on an average week.MarketBeat Follows1 people have added Sera Prognostics to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sera Prognostics insiders have not sold or bought any company stock.Percentage Held by Insiders15.60% of the stock of Sera Prognostics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 30.46% of the stock of Sera Prognostics is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Sera Prognostics are expected to decrease in the coming year, from ($1.28) to ($1.30) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sera Prognostics is -1.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sera Prognostics is -1.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSera Prognostics has a P/B Ratio of 0.60. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Sera Prognostics (NASDAQ:SERA) StockSera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.Read More SERA Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SERA Stock News HeadlinesSeptember 21, 2023 | finance.yahoo.comSERA PROGNOSTICS TO PRESENT AT CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE 2023August 31, 2023 | finance.yahoo.comSera Prognostics, Inc. (SERA) Loses -32.38% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerSeptember 26, 2023 | Legacy Research (Ad)WARNING: Mandatory U.S. Dollar Recall is Weeks AwayIf you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.August 30, 2023 | finance.yahoo.comSera Prognostics, Inc. (SERA) Loses -38.49% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerAugust 16, 2023 | finanznachrichten.deSera Prognostics, Inc.: Sera Prognostics Reports Second Quarter 2023 Financial ResultsAugust 11, 2023 | msn.comCitigroup Maintains Sera Prognostics Inc (SERA) Neutral RecommendationAugust 9, 2023 | finance.yahoo.comSERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTSAugust 9, 2023 | finance.yahoo.comSera Prognostics, Inc. (SERA) Reports Q2 Loss, Tops Revenue EstimatesSeptember 26, 2023 | Legacy Research (Ad)WARNING: Mandatory U.S. Dollar Recall is Weeks AwayIf you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.July 31, 2023 | finance.yahoo.comSera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2023 Financial Results on August 9, 2023June 28, 2023 | fool.comSera Prognostics (NASDAQ: SERA)June 8, 2023 | msn.comSera Prognostics: Buy The PreTRM MoatMay 25, 2023 | marketwatch.comSera Prognostics Reduces Headcount to Cut Costs in Optimization StrategyMay 25, 2023 | finance.yahoo.comSera Prognostics Announces Commercial Changes and Actions to Optimize Business for Market Success Toward Accelerating Test Adoption and RevenueMay 15, 2023 | msn.comSera Prognostics CEO Critchfield to step down in JuneMay 15, 2023 | finance.yahoo.comSera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEOMay 11, 2023 | finanznachrichten.deSera Prognostics, Inc.: Sera Prognostics Reports First Quarter 2023 Financial ResultsMay 10, 2023 | msn.comRecap: Sera Prognostics Q1 EarningsMay 10, 2023 | finance.yahoo.comSERA PROGNOSTICS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTSMay 10, 2023 | finance.yahoo.comSera Prognostics, Inc. (SERA) Reports Q1 LossMay 10, 2023 | marketwatch.comPremature Rupture of Membranes (PROM) Testing Market Report | Research Across The World 2031May 3, 2023 | benzinga.comSera Prognostics Stock (NASDAQ:SERA), DividendsApril 27, 2023 | finance.yahoo.comSera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2023 Financial Results on May 10, 2023April 24, 2023 | finance.yahoo.comSera Prognostics, Inc. (SERA) Loses -13.03% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerMarch 27, 2023 | finance.yahoo.comAll You Need to Know About Sera Prognostics, Inc. (SERA) Rating Upgrade to BuyMarch 27, 2023 | marketwatch.comLatest Premature Rupture of Membranes (PROM) Testing Market Growth Outlook 2023-2030 | New Report HighlightsMarch 27, 2023 | insidermonkey.comSera Prognostics, Inc. (NASDAQ:SERA) Q4 2022 Earnings Call TranscriptSee More Headlines Receive SERA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sera Prognostics and its competitors with MarketBeat's FREE daily newsletter. Email Address SERA Company Calendar Last Earnings8/09/2023Today9/26/2023Next Earnings (Estimated)11/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SERA CUSIPN/A CIK1534969 Webwww.seraprognostics.com Phone801-990-0520FaxN/AEmployees87Year FoundedN/APrice Target and Rating Average Stock Price Forecast$2.75 High Stock Price Forecast$2.75 Low Stock Price Forecast$2.75 Forecasted Upside/Downside+45.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.34) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-44,190,000.00 Net Margins-11,084.00% Pretax Margin-11,084.00% Return on Equity-44.05% Return on Assets-38.21% Debt Debt-to-Equity Ratio0.01 Current Ratio4.54 Quick Ratio4.54 Sales & Book Value Annual Sales$270,000.00 Price / Sales218.96 Cash FlowN/A Price / Cash FlowN/A Book Value$3.19 per share Price / Book0.59Miscellaneous Outstanding Shares31,280,000Free Float26,403,000Market Cap$59.12 million OptionableNot Optionable Beta0.33 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMs. Evguenia Lindgardt M.B.A. (Age 49)Interim Pres, CEO & Director Comp: $37.5kDr. Gregory C. Critchfield M.D. (Age 70)M.S., Exec. Director Comp: $790.74kDr. Steven W. GravesCo-Founder and Co-Chairman of The Scientific Advisory BoardDr. M. Sean Esplin M.D.Co-Founder and Co-Chairman of Scientific Advisory BoardMr. Austin AertsChief Financial Officer??Dr. John J. Boniface Ph.D. (Age 61)Chief Scientific Officer Mr. Robert G. Harrison (Age 57)Chief Information Officer Mr. Benjamin G. Jackson J.D. (Age 44)Gen. Counsel Dr. Paul Kearney Ph.D. (Age 55)Chief Data Officer More ExecutivesKey CompetitorsDermTechNASDAQ:DMTKPersonalisNASDAQ:PSNLEnzo BiochemNYSE:ENZTriSalus Life SciencesNASDAQ:TLSIMDxHealthNASDAQ:MDXHView All CompetitorsInsiders & InstitutionsCitadel Advisors LLCSold 8,516 shares on 8/15/2023Ownership: 0.039%BlackRock Inc.Bought 12,048 shares on 8/11/2023Ownership: 0.193%Marquette Asset Management LLCSold 14,845 shares on 7/28/2023Ownership: 0.115%Sanders Morris Harris LLCSold 73,270 shares on 7/11/2023Ownership: 1.170%Robert Gardner HarrisonSold 5,000 sharesTotal: $16,150.00 ($3.23/share)View All Insider TransactionsView All Institutional Transactions SERA Stock - Frequently Asked Questions Should I buy or sell Sera Prognostics stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sera Prognostics in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SERA shares. View SERA analyst ratings or view top-rated stocks. What is Sera Prognostics' stock price forecast for 2023? 2 Wall Street research analysts have issued 1-year price objectives for Sera Prognostics' shares. Their SERA share price forecasts range from $2.75 to $2.75. On average, they predict the company's share price to reach $2.75 in the next year. This suggests a possible upside of 45.5% from the stock's current price. View analysts price targets for SERA or view top-rated stocks among Wall Street analysts. How have SERA shares performed in 2023? Sera Prognostics' stock was trading at $1.26 on January 1st, 2023. Since then, SERA stock has increased by 50.0% and is now trading at $1.89. View the best growth stocks for 2023 here. When is Sera Prognostics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023. View our SERA earnings forecast. How were Sera Prognostics' earnings last quarter? Sera Prognostics, Inc. (NASDAQ:SERA) announced its quarterly earnings results on Wednesday, August, 9th. The company reported ($0.34) EPS for the quarter, meeting the consensus estimate of ($0.34). The business had revenue of $0.12 million for the quarter, compared to analysts' expectations of $0.10 million. Sera Prognostics had a negative net margin of 11,084.00% and a negative trailing twelve-month return on equity of 44.05%. When did Sera Prognostics IPO? (SERA) raised $75 million in an initial public offering (IPO) on Thursday, July 15th 2021. The company issued 4,687,500 shares at a price of $15.00-$17.00 per share. What is Sera Prognostics' stock symbol? Sera Prognostics trades on the NASDAQ under the ticker symbol "SERA." Who are Sera Prognostics' major shareholders? Sera Prognostics' stock is owned by many different retail and institutional investors. Top institutional investors include Sanders Morris Harris LLC (1.17%), BlackRock Inc. (0.19%), Marquette Asset Management LLC (0.11%) and Citadel Advisors LLC (0.04%). Insiders that own company stock include Benjamin Jackson, John J Boniface and Robert Gardner Harrison. View institutional ownership trends. How do I buy shares of Sera Prognostics? Shares of SERA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Sera Prognostics' stock price today? One share of SERA stock can currently be purchased for approximately $1.89. How much money does Sera Prognostics make? Sera Prognostics (NASDAQ:SERA) has a market capitalization of $59.12 million and generates $270,000.00 in revenue each year. The company earns $-44,190,000.00 in net income (profit) each year or ($1.34) on an earnings per share basis. How can I contact Sera Prognostics? The official website for the company is www.seraprognostics.com. The company can be reached via phone at 801-990-0520 or via email at peter@capcommpartners.com. This page (NASDAQ:SERA) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sera Prognostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.